Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Posner

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Nature|September 30, 2016
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancerJimi Kim, Elizabeth McMillan, Hyun Seok Kim, et al.
Cancer Discovery|July 14, 2026
CDK8 inhibition induces Mediator trapping and impairment of the EWSR1::FLI1 transcriptional program in Ewing sarcomaJames H McGinnis, Shuai Wang, Ryan A O'Hara, et al.
JCI Insight|July 26, 2022
Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibitionSm N Udden, Qian Wang, Sunil Kumar, et al.
Cell|November 19, 2013
Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancerHyun Seok Kim, Saurabh Mendiratta, Jiyeon Kim, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Benchmarking and optimizing Perturb-seq in differentiating human pluripotent stem cellsSushama Sivakumar, Yihan Wang, Sean C Goetsch, et al.
Stem Cell Reports|November 14, 2025
Benchmarking and optimizing Perturb-seq in differentiating human pluripotent stem cellsSushama Sivakumar, Yihan Wang, Sean C Goetsch, et al.
Cell|April 24, 2018
Chemistry-First Approach for Nomination of Personalized Treatment in Lung CancerElizabeth A McMillan, Myung-Jeom Ryu, Caroline H Diep, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Nature|September 30, 2016
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancerJimi Kim, Elizabeth McMillan, Hyun Seok Kim, et al.
Cancer Discovery|July 14, 2026
CDK8 inhibition induces Mediator trapping and impairment of the EWSR1::FLI1 transcriptional program in Ewing sarcomaJames H McGinnis, Shuai Wang, Ryan A O'Hara, et al.
JCI Insight|July 26, 2022
Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibitionSm N Udden, Qian Wang, Sunil Kumar, et al.
Cell|November 19, 2013
Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancerHyun Seok Kim, Saurabh Mendiratta, Jiyeon Kim, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Benchmarking and optimizing Perturb-seq in differentiating human pluripotent stem cellsSushama Sivakumar, Yihan Wang, Sean C Goetsch, et al.
Stem Cell Reports|November 14, 2025
Benchmarking and optimizing Perturb-seq in differentiating human pluripotent stem cellsSushama Sivakumar, Yihan Wang, Sean C Goetsch, et al.
Cell|April 24, 2018
Chemistry-First Approach for Nomination of Personalized Treatment in Lung CancerElizabeth A McMillan, Myung-Jeom Ryu, Caroline H Diep, et al.
Pageof 6